Technical Architecture Specification Summary

SAFECHAIN™

Technical Architecture Specification Summary

The Biopsychosocial Bridge™

1. System Overview

The Biopsychosocial Bridge™ is a secure procedural integrity platform designed to preserve institutional chain-of-custody across multi-agency safeguarding environments.

It operates as a compliance-layer architecture integrating:

  • Housing authorities

  • Police services

  • Courts

  • NHS Trusts

  • Legal representatives

The system centralises participation integrity documentation while maintaining strict role-based access and evidential continuity controls.

The platform is not clinical software.
It is institutional compliance infrastructure.

2. Architectural Objectives

The system is designed to:

  1. Preserve evidential continuity across agencies

  2. Document participation capacity variability (PCV)

  3. Log Equality Act reasonable adjustments

  4. Flag safeguarding triggers in real time

  5. Reduce retraumatisation caused by repeated disclosures

  6. Provide audit-ready documentation trails

  7. Support fiduciary defensibility under UK statutory duties

3. Core Architectural Components

3.1 Identity & Access Management (IAM)

  • Role-based access control (RBAC)

  • Multi-factor authentication (MFA)

  • Agency-scoped permissions

  • Participant-controlled consent layers

  • Access event logging

Ensures controlled disclosure and minimises unauthorised data exposure.

3.2 Participation Integrity Engine

Captures and documents:

  • Participation Capacity Variability (PCV classification)

  • Stress-proximal dysregulation events

  • Behavioural presentation context markers

  • Adjustment requests and implementation

Provides structured contextual documentation without clinical diagnosis.

3.3 Safeguarding Trigger Module

Monitors and logs:

  • Proximity-based distress indicators

  • Escalation flags

  • Cross-agency referral status

  • Safeguarding review checkpoints

Supports continuity between agencies without duplication.

3.4 Equality Act Compliance Ledger

Immutable logging system documenting:

  • Reasonable adjustments requested

  • Adjustments granted/declined

  • Decision rationale

  • Timestamped approval chains

Creates defensible audit trails aligned with Equality Act 2010 obligations.

3.5 Evidential Continuity Layer

Implements:

  • Tamper-evident audit logs

  • Timestamped data capture

  • Version-controlled documentation

  • Chain-of-custody traceability

  • Secure data retention policies

Ensures integrity suitable for court scrutiny.

3.6 Governance Dashboard

Executive-level analytics providing:

  • Adjustment compliance rates

  • Participation variability trends

  • Safeguarding incident metrics

  • Cross-agency delay indicators

  • Risk exposure modelling

Designed for board-level oversight and regulatory defensibility.

4. System Architecture Model

The Biopsychosocial Bridge™ follows a layered architecture:

Layer 1 – Secure Data Capture
Layer 2 – Contextual Interpretation Engine
Layer 3 – Compliance Logging Framework
Layer 4 – Audit & Governance Interface
Layer 5 – External Agency Integration APIs

The system is interoperable, not replacement infrastructure.

It overlays existing case management systems through API integration.

5. Security & Data Protection

Designed in alignment with:

  • UK GDPR

  • Data Protection Act 2018

  • ISO 27001 principles

  • NHS DSP Toolkit compatibility

  • Public sector security standards

Security Measures:

  • End-to-end encryption (AES-256 at rest, TLS 1.3 in transit)

  • Segmented database architecture

  • Zero-trust access model

  • Immutable audit logging

  • Automated anomaly detection

6. Interoperability

The system supports:

  • RESTful API integrations

  • Secure document exchange protocols

  • Structured metadata tagging

  • Role-based redaction controls

  • Cross-agency case ID mapping

The architecture does not centralise all raw agency data.
It centralises custodial integrity markers.

7. Data Model Summary

Core Data Objects:

  • Participant Record

  • Agency Interaction Log

  • PCV Classification Entry

  • Adjustment Log Entry

  • Safeguarding Trigger Record

  • Decision Rationale Record

  • Audit Event Record

Each object is timestamped and linked through relational indexing.

8. Compliance Alignment

The system is structured to support:

  • Equality Act 2010 documentation defensibility

  • Human Rights Act Article 6 procedural fairness

  • Domestic Abuse Act safeguarding continuity

  • Public law proportionality analysis

  • Professional regulatory standards

It strengthens defensibility rather than altering legal thresholds.

9. Operational Benefits

The Biopsychosocial Bridge™ provides:

  • Reduced institutional liability exposure

  • Lower risk of procedural unfairness claims

  • Improved safeguarding continuity

  • Reduced participant attrition

  • Strengthened regulatory audit outcomes

  • Measurable fiduciary compliance

10. System Boundaries

The platform does not:

  • Provide medical diagnosis

  • Replace legal advice

  • Offer therapeutic intervention

  • Interfere with judicial independence

It documents process integrity only.

11. Deployment Model

Proposed deployment environments:

  • Secure UK-based cloud hosting (ISO certified providers)

  • Multi-tenant architecture with institutional partitioning

  • Onboarding via phased pilot integration

  • Training embedded within SAFECHAIN™ accreditation pathway

12. Innovation Differentiator

Unlike standard case management systems, the Biopsychosocial Bridge™:

  • Integrates biological stress context into participation documentation

  • Formalises Equality Act logging as structured architecture

  • Preserves evidential chain-of-custody across agencies

  • Bridges legal, medical, and housing silos

  • Converts trauma-informed theory into measurable compliance infrastructure

This is not awareness training.

It is structural reform architecture.

Previous
Previous

Technology Readiness Level (TRL) Positioning StatementThe Biopsychosocial Bridge™

Next
Next

The Biopsychosocial Bridge™